返回档案库

案例库 · 产品与设计 · 产品决策 · 2024–2026

这条还没译成中文,下面是英文原文。

Adequan: glass fiber in the joint injection for dogs and horses

Four lots of Adequan canine and equine injections carry visible glass fiber — abscess and inflammation risk. Nationwide US; return or discard (31 Jul 2026).

American Regent · 2026-07-31

怎么回事

American Regent Animal Health recalled two lots each of Adequan Canine Injection (lots 25011, 3369) and Adequan i.m. Injection for horses (lots 24416, 25265P) on July 31, 2026 — testing found visible glass fiber material; an intramuscular injection carrying it can cause irritation, swelling, infection or abscesses.

The lots distributed nationwide to online pharmacies, wholesalers and veterinarians from May 2024 to January 2026. Owners stop use and contact their veterinarian; distributors return or discard. No adverse events reported.

A joint medicine whose own needle-path carries the shard it should never meet.

为什么会这样

  • Visible glass fiber in four lots of canine and equine injections — distributed May 2024–Jan 2026; recalled 31 Jul 2026
  • The vial is glass; the fiber is the container in the medicine — the making shed into the dose
  • The patients are animals who can't report the sting — the vet's eye is the surveillance
代价Four lots returned or discarded nationwide代价高昂

教训

A glass vial holds the medicine that must never contain glass. When fiber from the container reaches the dose, the packaging is the contamination — four lots deep.

资料来源

发现哪里写错了?告诉我们。

Comments · 0

    登录 后就能评论。

    类似的案例

    这家公司栽倒的地方,别处有人漂亮地解开过。 第二意见 →